PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 117 filers reported holding PROVENTION BIO INC in Q3 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,352,000 | +1767207.7% | 305,059 | +676.2% | 0.00% | – |
| Q4 2022 | $416 | -99.8% | 39,304 | +5.0% | 0.00% | – |
| Q3 2022 | $168,000 | +27.3% | 37,424 | +13.9% | 0.00% | – |
| Q2 2022 | $132,000 | -48.2% | 32,850 | -5.8% | 0.00% | – |
| Q1 2022 | $255,000 | +59.4% | 34,859 | +22.0% | 0.00% | – |
| Q4 2021 | $160,000 | -5.3% | 28,579 | +8.0% | 0.00% | – |
| Q3 2021 | $169,000 | -20.7% | 26,470 | +4.3% | 0.00% | – |
| Q2 2021 | $213,000 | -3.2% | 25,386 | +21.5% | 0.00% | – |
| Q1 2021 | $220,000 | -41.2% | 20,893 | -5.5% | 0.00% | – |
| Q4 2020 | $374,000 | +65.5% | 22,099 | +24.5% | 0.00% | – |
| Q3 2020 | $226,000 | +12.4% | 17,744 | +24.4% | 0.00% | – |
| Q2 2020 | $201,000 | – | 14,258 | +23663.3% | 0.00% | – |
| Q4 2018 | $0 | – | 60 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
| Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
| 683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
| Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
| GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
| RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
| Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
| Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
| Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |